The Medical Research Council (MRC), headquartered in Great Britain, is a leading organisation in the field of medical research. Established in 1913, the MRC has played a pivotal role in advancing health and medical knowledge through its extensive research initiatives across the UK and internationally. Focusing on various areas such as clinical trials, public health, and biomedical research, the MRC is renowned for its commitment to improving health outcomes. Its unique approach combines funding, support for researchers, and collaboration with academic and industry partners, positioning it as a key player in the global health landscape. With numerous significant achievements, including contributions to the development of vaccines and treatments, the MRC continues to be at the forefront of medical innovation, driving progress in health research for over a century.
How does Medical Research Council's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medical Research Council's score of 24 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, the Medical Research Council (MRC) reported a total of approximately 0 kg CO2e in emissions, with no specific data disclosed for Scope 1, Scope 2, or Scope 3 emissions. This lack of detailed emissions data suggests that MRC is in the early stages of its carbon accounting and reporting processes. MRC has committed to significant climate action, aligning with the overall UK Research and Innovation (UKRI) target of achieving net zero carbon emissions by 2040. As part of this commitment, MRC has set an interim target to reduce its Scope 1 and Scope 2 emissions by 50% by 2030, starting from a baseline year of 2017. This ambitious goal reflects MRC's dedication to enhancing its environmental sustainability and addressing climate change impacts. While specific emissions data is currently unavailable, MRC's proactive stance on setting reduction targets indicates a commitment to improving its carbon footprint in the coming years.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medical Research Council has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.